EVOKE PHARMA, INC. Research and Development in Process
EVOKE PHARMA, INC. reported Research and Development in Process of $650.00 thousand for the 86-month period ending 2014-03-31, per its 10-Q filed 2014-05-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentInProcess · last filed 2023-08-10
- 2014-03-31: Research and Development in Process 86 month $650.00K.
- 2013-12-31: Research and Development in Process 83 month $650.00K.
- 2013-09-30: Research and Development in Process 80 month $650.00K.
- 2007-06-30: Research and Development in Process 1 month $650.00K.
| Period end | Research and Development in Process 1 month | Research and Development in Process 80 month | Research and Development in Process 83 month | Research and Development in Process 86 month |
|---|---|---|---|---|
| 2014-03-31 | $650.00K 10-Q · filed 2014-05-13 | |||
| 2013-12-31 | $650.00K 10-K · filed 2014-03-25 | |||
| 2013-09-30 | $650.00K 10-Q · filed 2013-11-13 | |||
| 2007-06-30 | $650.00K 10-Q · filed 2023-08-10 |